Regeneron Pharmaceuticals Inc. v. Biogen Inc.: Discovery Application (South Korea)

Application by Regeneron Pharmaceuticals Inc. to take discovery from Biogen Inc. “for use in foreign patent-infringement litigation and related proceedings brought by Regeneron against Samsung Bioepis Co., Ltd., and Samsung Biologics Co., Ltd., currently pending in South Korea”, filed at the U.S. District Court for the District of Delaware.


  • 35
    April 27, 2023
    Regeneron Pharmaceuticals Inc.
    Xx Xx Xx
    Biogen Inc.
    Wilks Law, David Wilks, Kramer Levin Naftalis & Frankel